跳至主要内容
临床试验/ISRCTN36031640
ISRCTN36031640已完成不适用

Drinking water to dilute urine osmolality is associated with greater weight loss than drinking water following thirst in overweight pre-adolescents eating lower glycemic foods: A completer?s analysis of a controlled trial

Children's Hospital Oakland Research Institute (USA)0 个研究点目标入组 30 人开始时间: 2013年1月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. All participants were screened for a body mass index (BMI) above the 85th percentile for age and sex
  • 2. Motivation to lose weight
  • 3. Daily intake of caloric beverages, including juice, soda, milks, and/or sports drinks, less than 2L per day drinking water
  • 4. Willingness to adopt food and beverage changes
  • 5. Boys and girls, at any stage of puberty
  • 6. Who spoke English or Spanish

排除标准

  • 1. Any health condition that could make study participation harmful
  • 2. Acute illness
  • 3. A fluid balance disorder
  • 4. Any chronic condition or medication that stimulates vasopressin release, or any condition for which venipuncture is counter indicated.
  • 5. Potential participants were also excluded if they had any condition or medication known to promote weight gain.
  • 6. Specific exclusion criteria included:
  • 6.1. Renal disease (previous diagnosis, +3 proteinuria dipstick test, frequent urination)
  • 6.2. Congestive heart failure
  • 6.3. Adrenal insufficiency
  • 6.4. Syndrome of inappropriate secretion of antidiuretic hormone (SIADH)
  • 6.5. Chronic pain
  • 6.6. Psychogenic polydipsia
  • 6.7. Bleeding disorders
  • 6.8. Hemophila
  • 6.9. Recent cancer chemotherapy
  • 6.10. Syndromic conditions (e.g. Prader-Willi, Bardet-Biedl)
  • 6.11. Weight loss pharmacotherapy
  • 6.12. Anti-depressent, anti-psychotic or lipid-lowering medications, adrenergic or cholinergic drugs, clofibrate, chlorpropamide, carbamazepine, phenothiazines, vincristine, cyclophosphamide, morphine barbiturates, opiates, and glucocorticoid therapy in excess of physiologic dosing (i.e. > 15 mg/m2/d).
  • 7. Persons who had lost weight in the previous 2 months were excluded
  • 8. Persons who expressed aversion to drinking water or the prescribed study foods, or who had plans to move to a new address during the study period were also excluded from the study

研究者

发起方
Children's Hospital Oakland Research Institute (USA)

相似试验